Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandip Basu

Showing results (401-410 of 520) with videos related to

Pageof 52
Sort By:
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|February 9, 2025
Technetium-99m-labeled stealth liposomes: A new Strategy to Identify metastasis in tumour modelSwapna J Nabar, Tanuja Shet, Basant Malpani, et al.
Nuclear Medicine Communications|October 20, 2018
The rationality of combining second-generation antiandrogens with 177Lu-PSMA or its alpha-emitting congeners for better and durable results: will this dominate the therapeutic landscape and be an upfront consideration in metastatic castration-resistant prostate cancer in the coming years?Sandip Basu, Rahul V Parghane, Amit Joshi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 2, 2014
Examining recombinant human TSH primed ¹³¹I therapy protocol in patients with metastatic differentiated thyroid carcinoma: comparison with the traditional thyroid hormone withdrawal protocolDeepa Rani, Sushma Kaisar, Sushma Awasare, et al.
Nuclear Medicine Communications|August 14, 2023
Exploratory analysis of 64 CuCl 2 PET-CT imaging in carcinoma prostate and its comparison with 68 Ga-PSMA-11 and 18 F-FDG PET-CTAamir K Nazar, Ashwini Kalshetty, Rubel Chakravarty, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 23, 2011
Suboptimal and inadequate quantification: an alarming crisis in medical applications of PETSandip Basu, Thomas C Kwee, Drew Torigian, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 8, 2011
Active pre-treatment pure pulmonary parenchymal sarcoidosis with raised serum angiotensin converting enzyme level: characteristics on PET with glucose metabolism and cell proliferation tracers and HRCTSandip Basu, Makresh Yadav, J M Joshi, et al.
Nuclear Medicine Communications|November 7, 2008
FDG-PET and PET/CT in the clinical management of gastrointestinal stromal tumorSandip Basu, Kunissery Mallath Mohandas, Harish Peshwe, et al.
Clinical Microbiology Reviews|January 19, 2008
Role of modern imaging techniques for diagnosis of infection in the era of 18F-fluorodeoxyglucose positron emission tomographyRakesh Kumar, Sandip Basu, Drew Torigian, et al.
PET Clinics|May 10, 2016
Promising Roles of PET in Management of Arthroplasty-Associated InfectionBabak Saboury, Pouya Ziai, Molly Parsons, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 9, 2013
FDG PET imaging for diagnosing prosthetic joint infection: discussing the facts, rectifying the unsupported claims and call for evidence-based and scientific approachThomas C Kwee, Sandip Basu, Drew A Torigian, et al.
Pageof 52

Showing results (401-410 of 520) with videos related to

Sort By:
Pageof 52
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|February 9, 2025
Technetium-99m-labeled stealth liposomes: A new Strategy to Identify metastasis in tumour modelSwapna J Nabar, Tanuja Shet, Basant Malpani, et al.
Nuclear Medicine Communications|October 20, 2018
The rationality of combining second-generation antiandrogens with 177Lu-PSMA or its alpha-emitting congeners for better and durable results: will this dominate the therapeutic landscape and be an upfront consideration in metastatic castration-resistant prostate cancer in the coming years?Sandip Basu, Rahul V Parghane, Amit Joshi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 2, 2014
Examining recombinant human TSH primed ¹³¹I therapy protocol in patients with metastatic differentiated thyroid carcinoma: comparison with the traditional thyroid hormone withdrawal protocolDeepa Rani, Sushma Kaisar, Sushma Awasare, et al.
Nuclear Medicine Communications|August 14, 2023
Exploratory analysis of 64 CuCl 2 PET-CT imaging in carcinoma prostate and its comparison with 68 Ga-PSMA-11 and 18 F-FDG PET-CTAamir K Nazar, Ashwini Kalshetty, Rubel Chakravarty, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 23, 2011
Suboptimal and inadequate quantification: an alarming crisis in medical applications of PETSandip Basu, Thomas C Kwee, Drew Torigian, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 8, 2011
Active pre-treatment pure pulmonary parenchymal sarcoidosis with raised serum angiotensin converting enzyme level: characteristics on PET with glucose metabolism and cell proliferation tracers and HRCTSandip Basu, Makresh Yadav, J M Joshi, et al.
Nuclear Medicine Communications|November 7, 2008
FDG-PET and PET/CT in the clinical management of gastrointestinal stromal tumorSandip Basu, Kunissery Mallath Mohandas, Harish Peshwe, et al.
Clinical Microbiology Reviews|January 19, 2008
Role of modern imaging techniques for diagnosis of infection in the era of 18F-fluorodeoxyglucose positron emission tomographyRakesh Kumar, Sandip Basu, Drew Torigian, et al.
PET Clinics|May 10, 2016
Promising Roles of PET in Management of Arthroplasty-Associated InfectionBabak Saboury, Pouya Ziai, Molly Parsons, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 9, 2013
FDG PET imaging for diagnosing prosthetic joint infection: discussing the facts, rectifying the unsupported claims and call for evidence-based and scientific approachThomas C Kwee, Sandip Basu, Drew A Torigian, et al.
Pageof 52